Literature DB >> 1321205

The right end of the unique region of the genome of human herpesvirus 6 U1102 contains a candidate immediate early gene enhancer and a homologue of the human cytomegalovirus US22 gene family.

B J Thomson1, R W Honess.   

Abstract

The nucleotide sequence of a 12 kbp HindIII fragment (HindIII C) from the right end of the unique component of the genome of human herpesvirus 6 (HHV-6) (strain U1102) was determined. The sequence has a mean G + C content of 42% and contains approximately 28 copies of a tandemly repeated 104 to 107 bp element, which, with a single exception, contain a cleavage site for KpnI (the KpnI repeats). Each of these elements contains potential binding sites for transcription factors NF-kappa B and AP2. The KpnI repeats lie immediately upstream of a region previously identified as a candidate immediate early (IE) gene locus and therefore may constitute an IE gene enhancer element. One incomplete and six complete open reading frames (ORFs) were identified in the unique sequence of the HindIII C fragment. The predicted products of these ORFs do not include homologues of proteins encoded by members of the alpha- or gamma-herpesvirus sub-family. However, the HindIII C fragment does contain a homologue of the US22 gene family, previously found only in the beta-herpesvirus human cytomegalovirus (HCMV). These findings provide evidence that the close phylogenetic relationship between HHV-6 and HCMV is not confined to the beta-herpesvirus-specific arrangement of conserved replicative and structural genes which has been demonstrated previously.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321205     DOI: 10.1099/0022-1317-73-7-1649

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

Review 1.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 2.  Polydnavirus-facilitated endoparasite protection against host immune defenses.

Authors:  M D Summers; S D Dib-Hajj
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-03       Impact factor: 11.205

3.  Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A.

Authors:  G Dominguez; T R Dambaugh; F R Stamey; S Dewhurst; N Inoue; P E Pellett
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

4.  The R3 region, one of three major repetitive regions of human herpesvirus 6, is a strong enhancer of immediate-early gene U95.

Authors:  M Takemoto; T Shimamoto; Y Isegawa; K Yamanishi
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

5.  The U95 protein of human herpesvirus 6B interacts with human GRIM-19: silencing of U95 expression reduces viral load and abrogates loss of mitochondrial membrane potential.

Authors:  W M Yeo; Yuji Isegawa; Vincent T K Chow
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

6.  Structure and heterogeneity of the a sequences of human herpesvirus 6 strain variants U1102 and Z29 and identification of human telomeric repeat sequences at the genomic termini.

Authors:  B J Thomson; S Dewhurst; D Gray
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

7.  Structure and transcription of an immediate-early region in the human herpesvirus 6 genome.

Authors:  U Schiewe; F Neipel; D Schreiner; B Fleckenstein
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

8.  Nucleotide sequence analysis of a 38.5-kilobase-pair region of the genome of human herpesvirus 6 encoding human cytomegalovirus immediate-early gene homologs and transactivating functions.

Authors:  J Nicholas; M E Martin
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  Identification and characterization of a cDNA derived from multiple splicing that encodes envelope glycoprotein gp105 of human herpesvirus 6.

Authors:  B Pfeiffer; B Thomson; B Chandran
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.